Galmed Pharmaceuticals (EOCN) Cash & Current Investments (2013 - 2026)
Galmed Pharmaceuticals' Cash & Current Investments was $8.77 million in Q2 2026, down 32.9% from $13.06 million a year earlier and down 6.5% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Cash & Current Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Galmed Pharmaceuticals came in at $11.01 million, up 42.1% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of -27.8% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $7.75 million in FY2024 (-26.2%), $10.51 million in FY2023 (-28.9%), $14.77 million in FY2022 (-62.1%) and $38.99 million in FY2021 (-30.6%).
- The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q4 2024.
- Compared with a year earlier, Cash & Current Investments was higher in four of the last eight quarters, with growth averaging 46.9%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q4 2025 (growth of 432.7%); the worst was Q4 2022 (a decline of 91.0%).
- Per Business Quant data, EOCN's Cash & Current Investments in the three quarters before Q2 2026 was $9.37 million (Q1 2026), $11.01 million (Q4 2025) and $11.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Galmed Pharmaceuticals | 2.49 Mn | -38.20 Mn | - | 8.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.80 Mn |
| Mar 31, 2026 | 9.37 Mn |
| Dec 31, 2025 | 11.01 Mn |
| Sep 30, 2025 | 11.51 Mn |
| Jun 30, 2025 | 13.10 Mn |
| Mar 31, 2025 | 12.19 Mn |
| Dec 31, 2024 | 11.84 Mn |
| Sep 30, 2024 | 16.42 Mn |
| Jun 30, 2024 | 7.78 Mn |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 10.39 Mn |
| Sep 30, 2023 | 11.39 Mn |
| Jun 30, 2023 | 8.61 Mn |
| Mar 31, 2023 | 10.86 Mn |
| Dec 31, 2022 | 13.79 Mn |
| Sep 30, 2022 | 19.21 Mn |
| Jun 30, 2022 | 22.40 Mn |
| Mar 31, 2022 | 28.74 Mn |
| Dec 31, 2021 | 34.82 Mn |
| Sep 30, 2021 | 41.91 Mn |
API Access
Galmed Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();